Human Papillomavirus Is Linked to Cervical Cancer in Latin America

1989 ◽  
Vol 15 (3) ◽  
pp. 117
Keyword(s):  
Cervical Cancer ◽  
Latin America ◽  
Human Papillomavirus

scholarly journals Eliminating Deaths From Cervical Cancer—Report of a Panel at the 7th Annual Symposium on Global Cancer Research, a Satellite Meeting at the Consortium of Universities for Global Health 10th Annual Meeting

2019 ◽  
pp. 1-7
Author(s):  
Agnes Binagwaho ◽  
Patricia J. Garcia ◽  
Babacar Gueye ◽  
J. Andrew Dykens ◽  
Nothemba Simelela ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Research ◽  
Latin America ◽  
Human Papillomavirus ◽  
Global Health ◽  
World Health Organization ◽  
World Health ◽  
Annual Symposium ◽  
Human Papillomavirus Vaccination ◽  
Health Organization

This is a summary of the presentations addressing approaches and achievements to reach the goal of eliminating cervical cancer as a global public health problem that were delivered at the 7th Annual Symposium on Global Cancer Research at the 10th Annual Consortium of Universities for Global Health Meeting in March 2019. Dr Princess Nothemba Simelela, Assistant Director-General for Family, Women, Children and Adolescents, World Health Organization, gave an introduction to the World Health Organization–led Cervical Cancer Elimination Initiative and the emerging conceptual framework and targets that will shape the global 2020 to 2030 strategy. Subsequent presentations shared experiences from national programs in Rwanda (Agnes Binagwaho), Latin America (Patricia J. Garcia), and Senegal (Babacar Gueye and J. Andrew Dykens. Successes in intensified human papillomavirus vaccination and screening with follow-up treatment of early and advanced lesions detected are highlighted as well as the challenges and obstacles in achieving and maintaining high coverage in Africa and Latin America. With strong political leadership, commitment of national stakeholders, and the use of proven and cost-effective approaches to human papillomavirus vaccination, screening, and treatment, the vision of a world free of cervical cancer and saving women’s lives every year by preventing deaths from cervical cancer will be achievable in the next generation in all countries.

Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean

Vaccine ◽  
2008 ◽  
Vol 26 ◽  
pp. L16-L36 ◽  
Author(s):  
Maribel Almonte ◽  
Ginesa Albero ◽  
Mónica Molano ◽  
César Carcamo ◽  
Patricia J. García ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cervical Cancer ◽  
Latin America ◽  
Human Papillomavirus ◽  
The Caribbean

Integration of Human Papillomavirus Vaccination and Cervical Cancer Screening in Latin America and the Caribbean

Vaccine ◽  
2008 ◽  
Vol 26 ◽  
pp. L88-L95 ◽  
Author(s):  
Eduardo L. Franco ◽  
Vivien Tsu ◽  
Rolando Herrero ◽  
Eduardo Lazcano-Ponce ◽  
Allan Hildesheim ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Latin America ◽  
Human Papillomavirus ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Human Papillomavirus Vaccination ◽  
The Caribbean

scholarly journals Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala

2017 ◽  
Vol 3 (5) ◽  
pp. 444-454 ◽  
Author(s):  
Anna Gottschlich ◽  
Alvaro Rivera-Andrade ◽  
Edwin Grajeda ◽  
Christian Alvarez ◽  
Carlos Mendoza Montano ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Latin America ◽  
Human Papillomavirus ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Screening Method ◽  
Indigenous Communities ◽  
Developed Countries ◽  
Indigenous Community ◽  
Cervical Sample

Purpose Cervical cancer rates in Latin America are higher than those in developed countries, likely because of the lower prevalence of screening. Specifically, less than 40% of women in Guatemala are regularly screened and even fewer women are screened in indigenous communities. Current screening strategies—Pap smears and visual inspection with acetic acid—might not be the most effective methods for controlling cancer in these settings. We thus investigated the potential of self-collection of cervical samples with testing for human papillomavirus (HPV) to help prevent cervical cancer in an indigenous community in Guatemala. Patients and Methods A community representative random sample of 202 indigenous women age 18 to 60 years residing in Santiago Atitlan, Guatemala, were surveyed to assess knowledge of and risk factors for HPV and cervical cancer. Women were then invited to self-collect a cervical sample using HerSwab collection kits to assess the prevalence of HPV and the acceptability of self-sampling. Results Of 202 women who completed the survey, 178 (89%) provided a self-sample. In all, 79% of these women found the test comfortable, 91% found the test easy to use, and 100% reported they were willing to perform the test periodically as a screening method. Thirty-one samples (17%) were positive for at least one of 13 high-risk HPV types, and eight (4.5%) were positive for HPV 16/18. Conclusion HPV testing by using self-collected samples was well accepted, suggesting that it is a plausible modality for cervical cancer screening in indigenous communities. Further studies are needed to assess rates of follow-up after a positive test and to determine whether these findings extend to other indigenous and nonindigenous communities in Guatemala and Latin America.

Human Papillomavirus Infection and Cervical Cancer in Latin America

1989 ◽  
Vol 320 (22) ◽  
pp. 1437-1441 ◽  
Author(s):  
William C. Reeves ◽  
Louise A. Brinton ◽  
Mariana García ◽  
María M. Brenes ◽  
Rolando Herrero ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Latin America ◽  
Human Papillomavirus ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection

A combined ultrastructural and gene molecular research for the relationship between human uterine cervical carcinoma and human papillomavirus

1990 ◽  
Vol 48 (3) ◽  
pp. 204-205
Author(s):  
Kun Lee ◽  
Jingyi Si ◽  
Ricai Han ◽  
Wei Zhang ◽  
Bingbing Tan ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Intraepithelial Neoplasia ◽  
Hpv Infection ◽  
Dot Blot ◽  
Homologous Sequences ◽  
Normal Cervical Epithelium ◽  
The Relationship ◽  
Chronic Cervicitis

There are more supports for the view that human papillomavirus (HPV) infection might be an etiological factor in the development of cervical cancer when the association of persistent condylomata is considered. Biopsies from 318 cases with squamous cell carcinoma of uterine cervix, 48 with cervical and vulvar condylomata, 14 with cervical intraepithelial neoplasia (CIN), 34 with chronic cervicitis and 24 normal cervical epithelium were collected from 5 geographic regions of China with different cervical cancer mortalities. All specimens were prepared for Dot blot, Southern blot and in situ DNA-DNA hybridizations by using HPV-11, 16, 18 DNA labelled with 32P and 3H as probes to detect viral homologous sequences in samples. Among them, 32 cases with cervical cancer, 27 with condyloma and 10 normal cervical epitheliums were randomly chosen for comparative EM observation. The results showed that: 1), 192 out of 318 (60.4%) cases of cervical cancer were positive for HPV-16 DNA probe (Table I)

HPV-associated cervical diseases: screening, methods of examination, principles of treatment

GYNECOLOGY ◽  
2019 ◽  
Vol 21 (3) ◽  
pp. 6-8
Author(s):  
Vera N Prilepskaya
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cancer Prevention ◽  
Mortality Rates ◽  
Diagnostic Methods ◽  
Screening Methods ◽  
The Past ◽  
Associated Diseases ◽  
Principles Of Treatment ◽  
Cervical Diseases

This article presents information about modern principles of diagnosis and treatment of HPV-associated diseases. Behind cervical cancer morbidity and mortality rates over the past 10 years increase significantly. Examination and observation of patients with human papillomavirus persistence of highly oncogenic types is important a link in cancer prevention. The article presents diagnostic methods, treatment of cervical diseases, as well as the possibility of pharmacotherapy in HPV-associated diseases.

Sign in / Sign up

Export Citation Format

Share Document